# Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics

> **NCT01657760** · PHASE1 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 31 (actual)

## Conditions studied

- Alcohol Dependence

## Interventions

- **DRUG:** citalopram

## Key facts

- **NCT ID:** NCT01657760
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-01
- **Primary completion:** 2017-08-31
- **Final completion:** 2017-09-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2019-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01657760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01657760, "Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01657760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*